GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre: Q2 FY27 Revenue up 26.7% YoY to INR 2,553.9 Mn

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Nov 2026, 08:33 PM IST  ·  BSE ID: ee3e7b64-58e1-4c6f-a961-3597e54239dc
View Original BSE Filing (PDF)
💡
In Simple Terms
Vijaya Diagnostic Centre reported higher earnings for Q2 FY27 and expanded its network by acquiring a diagnostic centre in Guwahati.
🤖 AI Summary
  • Q2 FY27 revenue from operations for Vijaya Diagnostic Centre rose 26.7% YoY to INR 2,553.9 Mn.
  • Profit after Tax (PAT) for Q2 FY27 increased by 37.4% YoY to INR 594.7 Mn.
  • Company acquired Arya Wellness Centre in Guwahati, Assam, for ₹46.2 Cr, marking entry into North-East.
  • 2 hubs and 7 spokes commissioned in FY27, with plans for 3 more hubs and 7 spokes in H2 FY27.
  • EBITDA grew by 37.8% YoY to INR 1,127.5 Mn with a margin of 44.1% in Q2 FY27.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
2,553.9 Mn
26.7%
Profit after Tax (PAT) (Q2 FY27)
594.7 Mn
37.4%
EBITDA (Q2 FY27)
1,127.5 Mn
37.8%
Acquisition Cost (Arya Wellness Centre)
₹46.2 Cr.
EPS – Basic (Q2 FY27)
5.8 INR
37.2%
🏢 How This Affects the Company
📈
Business Impact
The acquisition of Arya Wellness Centre establishes Vijaya Diagnostic Centre's presence in the North-East region, expanding its geographical footprint beyond existing markets. Commissioning of 2 hubs and 7 spokes in FY27 and planned expansion strengthens network density and market reach.
💰
Financial Impact
Revenue from operations increased by 26.7% to INR 2,553.9 Mn in Q2 FY27, and Profit after Tax grew by 37.4% to INR 594.7 Mn, indicating improved financial performance. The acquisition of Arya Wellness Centre for ₹46.2 Cr represents a capital expenditure.
⚙️
Operational Impact
The new flagship hub in JP Nagar, Bengaluru, will serve as the central lab for the entire Bengaluru region, enhancing operational efficiency. The acquisition in Guwahati will provide an established operating platform in a new market.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results and investor presentation filing.
👤
Who Is Affected
Shareholders are affected by the company's improved financial performance, with Q2 FY27 PAT up 37.4% to INR 594.7 Mn, and an EPS (Basic) of INR 5.8.
🔍
Management Signal
Management's commentary and actions signal a focus on sustained organic growth, strategic geographical expansion through acquisitions, and investment in network infrastructure and technology.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
H2 FY27 expansion updates — observe commissioning of 3 hubs & 7 spokes.
Q3 FY27 financial results — check if revenue and profit growth momentum is sustained.
Integration progress of Arya Wellness Centre in Guwahati from January 1, 2027.
LOW RISK The filing indicates positive financial results and strategic expansion plans with no immediate risks highlighted.
💡 Investor Takeaway
Vijaya Diagnostic Centre reported robust Q2 FY27 financial results with revenue from operations at INR 2,553.9 Mn, up 26.7% YoY, and PAT at INR 594.7 Mn, a 37.4% YoY increase. The acquisition of Arya Wellness Centre for ₹46.2 Cr marks a strategic entry into the North-East region.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 Revenue from Operations increased by 26.7% YoY to INR 2,553.9 Mn, demonstrating sustained growth momentum.
  • Q2 FY27 Profit after Tax (PAT) grew by 37.4% YoY to INR 594.7 Mn, alongside a PAT Margin increase to 23.3% from 21.5%.

⚠️ Concerns

  • Finance costs increased by 45.4% YoY to INR 113.8 Mn in Q2 FY27, which is a higher growth rate than revenue.
  • Other income decreased by 20.8% YoY to INR 49.5 Mn in Q2 FY27, impacting overall profitability contribution.
📅 Company Track Record
In Q1 FY27, Vijaya Diagnostic Centre reported a 22.8% YoY revenue increase and a 37.6% rise in PAT to INR 531.0 Mn. The current Q2 FY27 results show continued strong growth, with revenue up 26.7% and PAT up 37.4% YoY, indicating a consistent upward trend in performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Vijaya Diagnostic Centre's revenue in Q2 FY27?
Vijaya Diagnostic Centre's revenue from operations in Q2 FY27 was INR 2,553.9 Mn, representing a 26.7% increase year-on-year.
What was the Profit after Tax (PAT) for Vijaya Diagnostic Centre in Q2 FY27?
The Profit after Tax (PAT) for Vijaya Diagnostic Centre in Q2 FY27 was INR 594.7 Mn, an increase of 37.4% compared to Q2 FY26.
What was the acquisition cost for Arya Wellness Centre by Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre acquired Arya Wellness Centre in Guwahati, Assam, for ₹46.2 Cr.
How many new centres did Vijaya Diagnostic Centre commission in FY27?
Vijaya Diagnostic Centre has commissioned 2 hubs and 7 spokes so far in FY27, with plans for another 3 hubs and 7 spokes in H2 FY27.
What was Vijaya Diagnostic Centre's EBITDA in Q2 FY27?
Vijaya Diagnostic Centre's EBITDA in Q2 FY27 was INR 1,127.5 Mn, with an EBITDA margin of 44.1%, marking a 37.8% YoY growth.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.